Shareholder proposals to expand access to Covid-19 vaccines are rejected

Investors in three Covid-19 vaccine makers on Thursday rejected shareholder proposals to expand global access to vaccines.

Pfizer Modern and Johnson & Johnson had opposed the proposals, saying they had already taken steps to expand access to their vaccines in poorer countries.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button